Correlation between bone mineral density and oxidative stress in postmenopausal women

Indian Journal of Endocrinology and Metabolism

Volumn 19, Issue 4, 2015, Pages 491-497

  Sharma, Tripti ^a   Islam, Najmul ^a   Ahmad, Jamal ^a   Akhtar, Nishat ^a   Beg, Mujahid ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

BMD; correlation; oxidative stress; postmenopausal women

Indexed keywords

EID: 84981225508     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.159053     Document Type: Article

References (25)

1. Salim A, Nacamuli RP, Morgan EF, Giaccia AJ, Longaker MT. Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem 2004;279:40007-16.
2. Gur A, Sarac AJ, Nas K, Cevik R. The relationship between educational level and bone mineral density in postmenopausal women. BMC Fam Pract 2004;5:18.
3. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, et al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 1989;125:1805-13.
4. Bergamini CM, Gambetti S, Dondi A, Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 2004;10:1611-26.
5. Pansini F, Mollica G, Bergamini CM. Management of the menopausal disturbances and oxidative stress. Curr Pharm Des 2005;11:2063-73.
6. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: An inflammatory tale. J Clin Invest 2006;116:1186-94.
7. Cervellati C, Bonaccorsi G, Cremonini E, Bergamini CM, Patella A, Castaldini C, et al. Bone mass density selectively correlates with serum markers of oxidative damage in post-menopausal women. Clin Chem Lab Med 2013;51:333-8.
8. Harlow SD, Crawford S, Dennerstein L, Burger HG, Mitchell ES, Sowers MF, et al. Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging. Climacteric 2007;10:112-9.
9. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. London: Academic Press; 1974. p. 671-84.
10. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller DJ. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Res 1984;44:5086-91.
11. Matés JM, Segura JM, Perez-Gomez C, Rosado R, Olalla L, Blanca M, et al. Antioxidant enzymatic activities in human blood cells after an allergic reaction to pollen or house dust mite. Blood Cells Mol Dis 1999;25:103-9.
12. Hasan N, Yusuf N, Toossi Z, Islam N. Suppression of Mycobacterium tuberculosis induced reactive oxygen species (ROS) and TNF-alpha mRNA expression in human monocytes by allicin. FEBS Lett 2006;580:2517-22.
13. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989;179:8-18.
14. Jansen EH, Ruskovska T. Comparative analysis of serum (Anti) oxidative Status Par-meters in Healthy Persons. Int J Mol Sci 2013;14:6106-15.
15. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem 1996;239:70-6.
16. Masi L, Brandi ML. Physiopathological basis of bone turnover. Q J Nucl Med 2001;45:2-6.
17. Lindsay R. Estrogen deficiency. In: Riggs BL, Melton LJ, editors. Osteoporosis: Etiology, Diagnosis, and Management. 2nd ed. Philadelphia, Pa, USA: Lippincott-Raven; 1996. p. 133-60.
18. Cervellati C, Bonaccorsi G, Cremonini E, Bergamini CM, Patella A, Castaldini C, et al. Bone mass density selectively correlates with serum markers of oxidative damage in post-menopausal women. Clin Chem Lab Med 2013;51:333-8.
19. Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi A. Oxidative stress and reactive oxygen species. Contrib Nephrol 2005;149:240-60.
20. Sanchez-Rodriguez MA, Ruiz-Ramos M, Correa-Munoz E, Mendoza-Nunez VM. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 2007;8:124.
21. Sontakke AN, Tare RS. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin Chim Acta 2002;318:145-8.
22. Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, et al. Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study. J Clin Endocrinol Metab 2003;88:1523-7.
23. Dreher I, Schütze N, Baur A, Hesse K, Schneider D, Köhrle J, et al. Selenoproteins are expressed in fetal human osteoblast-like cells. Biochem Biophys Res Commun 1998;245:101-7.
24. Hahn M, Conterato GM, Frizzo CP, Augusti PR, da Silva JC, Unfer TC, et al. Effects of bone disease and calcium supplementation on antioxidant enzymes in postmenopausal women. Clin Biochem 2008;41:69-74.
25. Ozgocmen S, Kaya H, Fadillioglu E, Aydogan R, Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 2007;295:45-52.